Zimmer Holdings, Inc. (NYSE and SIX: ZMH) (“Zimmer”) announced today that it has proposed a revised remedy package to the European Commission (the “EC”) to facilitate the EC’s approval of Zimmer’s proposed acquisition of Biomet. The revised remedy package submitted by Zimmer is generally consistent with the initial remedy package proposed in December 2014 and …read more.